Expression Pattern of SLIT 2 Genes Discriminates Malignant from Benign Canine Mammary Tumours
DOI:
https://doi.org/10.48165/ijvsbt.19.1.01Keywords:
Histopathology, Mammary tumours, Quantitative real-time PCR, SLIT2 genesAbstract
The study was conducted to investigate the expression of SLIT2 gene in representative tissue samples of mammary tumours of female dogs (n=10) with the age between 5.0 and 16.5 years brought to Veterinary Clinical Complex, LUVAS, Hisar. Excisional biopsy was taken after surgery of these cases. Histopathological studies confirmed four cases of adenocarcinoma, three cases of benign mixed tumours and two of myoepithelioma and one case of adenoma. Amplification plots and dissociation curves of RT-qPCR were indicative of specific amplification of the canine SLIT 2 gene in all the samples. Further, amplification product of a 160 bp SLIT 2 gene and 120 bp β-actin gene in all the RT-qPCR tubes were visible by 2% agarose gel electrophoresis. Out of 10 tissue samples examined, transcript levels of SLIT 2 genes in all different samples ranged from 1.90 to 84.98. Conclusively, the expression of SLIT 2 genes increased in all canine malignant mammary gland tumours, thereby showing its association with tumour malignancy.
Downloads
References
Hussain, S., Saxena, S., Shrivastava, S., Mohanty, A.K., Kumar, S., Singh, R.J., Kumar, A., Wani, S.A., Gandham, R.K., Kumar, N., Sharma, A.K., Tiwari, A.K., & Singh, R.K. (2018). Gene expression profiling of spontaneously occurring canine mammary tumours: Insight into gene networks and pathways linked to cancer pathogenesis. PLoS ONE, 13(12), e0208656.
Klopfleisch, R., Klose, P., & Gruber, A.D. (2010). The combined expression pattern of BMP2, LTBP4, and DERL1 discriminates malignant from benign canine mammary tumors. Veterinary Pathology, 47(3), 446-454.
Klopfleisch, R., Klose, P., Weise. C., Bondzio. A., Multhaup. G., Elinspanier. R., & Gruber, AD. (2011). Proteome of metastatic canine mammary carcinomas: similarities to and differences from human breast cancer. Journal of Proteome Research, 2, 6380-91.
Kumar, P., & Parasar, M.C. (2020). Occurrence of mammary tumour in dogs. Journal of Agricultural Research Advances, 2(2), 29-32.
Lee, C., & Kweon, O. (2002). Mutations of p53 Tumor Suppressor Gene in Spontaneous Canine mammary tumors. Journal of Veterinary Science, 3(4), 321-325.
Livak, K.J., & Schmittgen, T.D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2–∆∆Ct method. Methods, 25, 402-408.
Muthuswamy, S.K., Li, D., Lelievre, S., Bissell, M.J., & Brugge J.S. (2001). ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nature Cell Biology, 3, 785-792.
Nieto, A., Perez-Alenza, M.D., Del Castillo, N., Tabanera, E., Castano, M., & Pena, L. (2003). BRCA1 expression in canine mammary dysplasias and tumours: relationship with prognostic variables. Journal of Comparative Pathology, 128, 260-268.
Queiroga, F.L., Raposo, T., Carvalho, M.I., Prada, J., & Pires, I. (2011). Canine mammary tumours as a model to study human breast cancer: most recent findings. In Vivo. 25(3), 455-465.
Saharan, S., Singh, P., Singh, A. Gupta, R.P., & Dutt, R. (2022). Sonographic and histopathological study of mammary tumours in female dogs. Applied Biological Research, 24(2), 245-250.
Stan, F., Gudea, A., Damian, A., Gal, A.F., Papuc, I., Alexandru Raul Pop, A.R., & Cristian M. (2020). Ultrasonographic algorithm for the assessment of sentinel lymph nodes that drain the mammary carcinomas in female dogs. Animals, 10, 2366.
Tanno, T., Yuchie, T., Takaaki, S., Hideo, A., Shigeo, T., Mitsuru, K., Jyoji, Y., Fumihito, O., Kihei, K., & Shingo, T. (2006). Expression patterns of the slit subfamily mRNA in canine malignant mammary tumors. Journal of Veterinary Medical Science, 68(11), 1173-1177.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
